Literature DB >> 33119196

Age-based preferences for risk communication in the fentanyl era: 'A lot of people keep seeing other people die and that's not enough for them'.

Christine M Gunn1, Ariel Maschke1, Miriam Harris2, Samantha F Schoenberger2, Spoorthi Sampath3, Alexander Y Walley4, Sarah M Bagley5.   

Abstract

AIMS: To explore how people who use fentanyl and health-care providers engaged in and responded to overdose risk communication interactions, and how these engagements and responses might vary by age.
DESIGN: A single-site qualitative in-depth interview study.
SETTING: Boston, MA, United States. PARTICIPANTS: The sample included 21 people (10 women, 11 men) who were either 18-25 or 35+, English-speaking, and reported illicit fentanyl use in the last year and 10 health-care providers who worked directly with people who use fentanyl (PWUF) in clinical and community settings. MEASUREMENTS: Open-ended, flexible interview questions guided by a risk communication framework were used in all interviews. Codes used for thematic analysis included deductive codes related to the risk communication framework and inductive, emergent codes from interview content.
FINDINGS: We identified potential age-based differences in perceptions of fentanyl overdose, including that younger participants appeared to display more perceptions of an immunity to fentanyl's lethality, while older people seemed to express a stronger aversion to fentanyl due to its heightened risk of fatal overdose, shorter effects and potential for long-term health consequences. Providers perceived greater challenges relaying risk information to young PWUF and believed them to be less open to risk communication. Compassionate harm reduction communication was preferred by all participants and perceived to be delivered most effectively by community health workers and peers. PWUF and providers identified structural barriers that limited compassionate harm reduction, including misalignment of available treatment with preferred options and clinical structures that impeded the delivery of risk communication messages.
CONCLUSIONS: Among people who engage in illicit fentanyl use, fentanyl-related risk communication experiences and preferences may vary by age, but some foundational elements including compassionate, trust-building approaches seem to be preferred across the age spectrum. Structural barriers in the clinical setting such as provider-prescribing power and infrequent encounters may impede the providers' ability to provide compassionate harm reduction communication.
© 2020 Society for the Study of Addiction.

Entities:  

Keywords:  Age-based preferences; drug overdose; fentanyl; harm reduction; qualitative; risk communication

Year:  2020        PMID: 33119196      PMCID: PMC8081736          DOI: 10.1111/add.15305

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  54 in total

1.  The Effect of Motivational Interviewing on Prescription Opioid Adherence Among Older Adults With Chronic Pain.

Authors:  Yu-Ping Chang; Peggy Compton; Pamela Almeter; Chester H Fox
Journal:  Perspect Psychiatr Care       Date:  2014-08-27       Impact factor: 2.186

2.  Addressing the Nation's Opioid Epidemic: Lessons from an Unsanctioned Supervised Injection Site in the U.S.

Authors:  Alex H Kral; Peter J Davidson
Journal:  Am J Prev Med       Date:  2017-08-08       Impact factor: 5.043

3.  Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.

Authors:  Daniel Ciccarone; Jeff Ondocsin; Sarah G Mars
Journal:  Int J Drug Policy       Date:  2017-07-18

4.  Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes.

Authors:  Montserrat Neira-León; Gregorio Barrio; María J Bravo; M Teresa Brugal; Luis de la Fuente; Antonia Domingo-Salvany; José Pulido; Sara Santos
Journal:  Int J Drug Policy       Date:  2010-08-30

5.  Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model.

Authors:  Laura C Fanucchi; Sharon L Walsh; Alice C Thornton; Michelle R Lofwall
Journal:  Prev Med       Date:  2019-06-26       Impact factor: 4.018

6.  Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.

Authors:  Michele Calvo; Jessica MacFarlane; Heather Zaccaro; Matthew Curtis; María Cabán; Jamie Favaro; Marian R Passannante; Taeko Frost
Journal:  Drug Alcohol Depend       Date:  2017-06-15       Impact factor: 4.492

Review 7.  Peer-Delivered Recovery Support Services for Addictions in the United States: A Systematic Review.

Authors:  Ellen L Bassuk; Justine Hanson; R Neil Greene; Molly Richard; Alexandre Laudet
Journal:  J Subst Abuse Treat       Date:  2016-01-13

8.  Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial.

Authors:  Phillip Oliver Coffin; Glenn-Milo Santos; Tim Matheson; Emily Behar; Chris Rowe; Talia Rubin; Janelle Silvis; Eric Vittinghoff
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

9.  Multiple Fentanyl Overdoses - New Haven, Connecticut, June 23, 2016.

Authors:  Anthony J Tomassoni; Kathryn F Hawk; Karen Jubanyik; Daniel P Nogee; Thomas Durant; Kara L Lynch; Rushaben Patel; David Dinh; Andrew Ulrich; Gail D'Onofrio
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-03       Impact factor: 17.586

10.  Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States.

Authors:  Karin A Mack; Christopher M Jones; Michael F Ballesteros
Journal:  MMWR Surveill Summ       Date:  2017-10-20
View more
  4 in total

1.  Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019.

Authors:  Xinyi Jiang; Gery P Guy; Christopher Dunphy; Cassandra M Pickens; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2021-10-30       Impact factor: 4.492

2.  "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.

Authors:  Sarah S Shin; Kate LaForge; Erin Stack; Justine Pope; Gillian Leichtling; Jessica E Larsen; Judith M Leahy; Andrew Seaman; Daniel Hoover; Laura Chisholm; Christopher Blazes; Robin Baker; Mikaela Byers; Katie Branson; P Todd Korthuis
Journal:  Harm Reduct J       Date:  2022-07-11

3.  Competing risks of women and men who use fentanyl: "The number one thing I worry about would be my safety and number two would be overdose".

Authors:  Miriam T H Harris; Sarah M Bagley; Ariel Maschke; Samantha F Schoenberger; Spoorthi Sampath; Alexander Y Walley; Christine M Gunn
Journal:  J Subst Abuse Treat       Date:  2021-01-27

4.  "We need to build a better bridge": findings from a multi-site qualitative analysis of opportunities for improving opioid treatment services for youth.

Authors:  Kirsten Marchand; Oonagh Fogarty; Katrina Marie Pellatt; Kayly Vig; Jordan Melnychuk; Christina Katan; Faria Khan; Roxanne Turuba; Linda Kongnetiman; Corinne Tallon; Jill Fairbank; Steve Mathias; Skye Barbic
Journal:  Harm Reduct J       Date:  2022-04-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.